August 26, 2024
UCB Divests Chinese Production Plant and Older Medications for $680 Million
UCB, production plant, older medications, China, $680M, pharmaceutical industry, divestment
Siemens Healthineers Expands into Europe with Acquisition of Novartis’ Radiodiagnostic Manufacturing Network
Siemens Healthineers, Novartis, Acquisition, Radiodiagnostic Manufacturing Network, Europe, PET Radiopharmaceuticals
Galapagos Investor Seeks to Influence Company Control, Citing Undervaluation
Galapagos, investor influence, undervaluation, biotech, corporate control
Johnson & Johnson’s 340B Drug Discount Policy Change Rejected by HHS
Johnson & Johnson, 340B drug discount program, Stelara, Xarelto, HHS, HRSA, drug pricing, hospital payments
Federal Agency Rejects J&J’s 340B Rebate Model, Vows to Take Action
340B Program, Johnson & Johnson, Rebate Model, Federal Agency Opposition, Healthcare Policy
Procept BioRobotics Receives FDA Clearance for Advanced Prostate Surgery Robot
Procept BioRobotics, FDA Clearance, Prostate Surgery Robot, Aquablation Therapy, AI-Powered Platform
Biotech IPO Market Sees Shifts in Funding and Investor Appetite
biotech IPOs, crossover funding, venture capital, clinical-stage assets, market correction, investor demand
Tome Biosciences, a High-Profile Gene Editing Startup, Announces Massive Layoffs and Sale Plans
Tome Biosciences, gene editing, layoffs, startup, biotech, financial struggles